Amanda Reiff, MPH Epidemiologist Jefferson County Public Health

Slides:



Advertisements
Similar presentations
Antibiogram in Washoe County Nevada – Know the Local Data, Prevent Antimicrobial Resistance Lei Chen, Ph.D., Senior Epidemiologist, Washoe County.
Advertisements

Robynn Cheng Leidig, MPH
I AM NOT HOMELESS CSTE JUNE 2013 Dee Pritschet, TB Controller – North Dakota Department of Health Shawn McBride, Epidemiologist – North Dakota Department.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
Carbapenemase- Producing Carbapenem-Resistant Enterobacteriaceae Nicole Hearon, HAI Epidemiologist Surveillance and Investigation Division Indiana State.
Severe Acute Respiratory Syndrome (SARS) and Preparedness for Biological Emergencies 27 April 2004 Jeffrey S. Duchin, M.D. Chief, Communicable Disease.
1 Antibiotic Resistance: An Update Janice Soreth, M.D. Director Division of Anti-Infective Drug Products February 20, 2002.
Lyle Moore Resiliency Officer Office of Emergency Preparedness and Response.
Lyle Moore Resiliency Officer Office of Emergency Preparedness and Response.
Jean B. Patel, PhD, D(ABMM) Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic Infectious Disease Centers for Disease Control.
Laboratory diagnoses of infections agents. DIFFERENT TYPES OF AND APPROACHES TO CLINICAL SAMPLE COLLECTION.
Lyle Moore Resiliency Officer Office of Emergency Preparedness and Response.
Mumps Outbreaks Associated with Correctional Facilities Texas
Using Vaccine Preventable Disease Surveillance Indicators for Evaluation (of Reporting to CDC) Denise Woods-Stout Vaccine Preventable Disease Surveillance.
MRSA Methicillin-resistant Staphylococcus Aureus
S. aureus subtypes based on Methicillin resistance
Tapasyapreeti Mukhopadhyay, Vrushali Patwardhan, Sarman Singh
National Tuberculosis Genotyping Service
Antibiotic-resistant Bacteria
Point Prevalence Survey in a Long Term Care Facility, 2016
Table 1 Demographic and clinical characteristics of 758 admitted patients for whom cultures of nares were performed to assess methicillin-resistant Staphylococcus.
Antibiotic Stewardship in Pennsylvania
Vibrio Reporting and Surveillance in Louisiana
Ear culture D. M. M. Lab..
MRSA: Implications in Sports Medicine
Vibrio parahaemolyticus in Virginia
Stevce Acevski PhD Alkaloid AD ISPOR Macedonia
مقدمه کوروناویروس ها ویروس های بزرگی هستند که باعث بيماري هاي متنوعي در بسياري از حيوانات مي شوند و درگذشته به عنوان عامل سرماخوردگی انسان شناخته.
MFHCC Meeting November 1, 2016
CSI 101 Skills Lab 3 Universal Precautions and
E. Monee’ Carter-Griffin DNP, RN, ACNP-BC
Maria del Rosario, MD, MPH Arianna DeBarr, RN, BSN
Chapter 1: Introduction to Multidrug – Resistant Organisms
Unit 21:Biomedical Science
Report Back Track 6: Population Health Track
Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.
Active Surveillance for EHF Cases, Equateur Province, DR Congo (Zaire), November-December 1976
Patricia A. Somsel, Dr.P.H. Michigan Department of Community Health
Clarifying CRE Reporting in NHSN
Is the prevalence of antibiotic-resistant organisms changing in Canadian hospitals? Comparison of point-prevalence survey results in 2010 and 2012  V.
A multicentre analysis of epidemiology of the nosocomial bloodstream infections in Japanese university hospitals  M. Nagao  Clinical Microbiology and.
Molecular characterization and susceptibility of methicillin-resistant and methicillin- susceptible Staphylococcus aureus isolates from hospitals and the.
P. Moreillon, J.M. Entenza  Clinical Microbiology and Infection 
Homework Packet 13 due tomorrow
Bacterial resistance—the clinical challenge
SEPARATE YOUR PAPER INTO (3) DIFFERENT SECTIONS COCCI BACILLI SPIRILLA
Strategies for managing today's infections
ANTIBIOTICS AND SUPERBUGS.
Reusable maps and graphs from ECDC Communicable Disease Threats Report Week 9, 2019 You are encouraged to reuse our maps and graphs for your own purposes.
Clinical profile of ceftobiprole, a novel β-lactam antibiotic
Effectiveness of a hospital-wide selective screening programme for methicillin-resistant Staphylococcus aureus (MRSA) carriers at hospital admission to.
Can β-lactams be re-engineered to beat MRSA?
Methicillin-resistant Staphylococcus aureus (MRSA) with reduced susceptibility to glycopeptides (GISA) in 63 French general hospitals  G.L. Cartolano,
Strain relatedness of meticillin-resistant Staphylococcus aureus isolates recovered from patients with repeated bacteraemia  C-H. Liao, C-C. Lai, S-Y.
Specimen Submission Requirements Update and Lab Discussion
Using Whole Genome Sequencing Analysis in California
National Center for Emerging and Zoonotic Infectious Diseases
Dominique Cavallo, Sharlonda Pierce, MPH, MAEd
Chapter 4: Reporting and Submitting VISA/VRSA in Texas
J. Wilson, S. Elgohari, D. M. Livermore, B. Cookson, A. Johnson, T
Terminology relating to methods for the determination of susceptibility of bacteria to antimicrobial agents    Clinical Microbiology and Infection  Volume.
Abstracts accepted for publication only
INFECTIOUS DISEASES CLERKSHIP –
G.C. Schito  Clinical Microbiology and Infection 
Number of ventilator-associated pneumonia (VAP) patients with newly isolated micro-organisms from endotracheal aspirates after initiation of antibiotic.
D.A. Robinson, M.C. Enright  Clinical Microbiology and Infection 
Laura Lane, Epidemiologist
EARS-Net results 2011 Ole Heuer
Varicella Vaccine Efficacy Estimates
Lab Results + RVCT Notification=
Presentation transcript:

Amanda Reiff, MPH Epidemiologist Jefferson County Public Health Changes to Rules and Regulations Pertaining to Epidemic and Communicable Disease Control Training Amanda Reiff, MPH Epidemiologist Jefferson County Public Health

Update from CDPHE Board of Health accepted the proposed changes on September 16, 2015 for the Rules and Regulations Pertaining to Epidemic and Communicable Disease Control (6 CCR 1009-1). Will be effective on November 14, 2015 For newly reportable conditions, the Colorado Electronic Disease Reporting System (CEDRS) will be available to receive reports on November 14, 2015

Effective: October 15, 2014

Changes To better explain who must report conditions (Labs and/or individuals) and the required timing (24hrs vs 7 days): Regulations 1-3 were combined to create a single table.

Changes Accession number is required on all reported diseases with supporting laboratory results to comply with CDC reporting requirements and be able to link multiple tests performed on the same specimen.

Changes Clinical and reference laboratories are required to submit cultures or original clinical material for specific reportable conditions as listed in the reportable disease table. Laboratories will submit bacterial culture isolates or patient clinical material that yields positive findings to the CDPHE Laboratory Services Division.

Changes Methicillin-resistant Staphylococcus aureus (MRSA) is deleted from the “Conditions Reportable by all Laboratories.”

Changes The definition of carbapenem-resistant Enterobacteriaceae (CRE) is changed. See regulations for new definition. CDPHE will reach out individually to labs that are part of the Emerging Infections Program (EIP) to discuss reporting. CRE remains a 7 day reportable condition CDC 2013

Changes Carbapenem-resistant Pseudomonas aeruginosa (CRPA) is added as a 7 day reportable condition by laboratories. CDPHE will reach out individually to labs that are part of the Emerging Infections Program (EIP) to discuss reporting. Image Left: CDC staff show 2 plates growing bacteria in the presence of discs containing various antibiotics. The isolate on the left plate is susceptible to the antibiotics on the discs and unable to grow around the discs. The disc on the right has a CRE that is resistant to all the antibiotics tested and is able to grow near the discs. Image Right: This is a plate that demonstrates the modified Hodge Test which identifies resistance in Enterobacteriaceae. Bacteria that are resist to Carbapenems, which are typically “last resort” antibiotics, produce distinctive clover-leaf shape.

Changes Viral hemorrhagic fever is added as a 24hr reportable condition by individuals AND laboratories. Includes: Ebola virus disease, Crimean-Congo hemorrhagic fever, Lassa fever, Marburg fever, and more.

Changes Severe or Novel Coronavirus is added as a 24hr reportable condition by individuals AND Laboratories. Includes: SARS and MERS-CoV

Changes Tularemia is changed from a 7 day reportable to 24hr reportable disease.

Changes Acute flaccid myelitis (AFM) is added as a 7 days reportable condition. Definition can be found on CDPHE website

Changes When a laboratory performs a culture that is positive for Mycobacterium tuberculosis, the lab shall store the isolate until it receives a request from the state or local health department for the isolate OR the lab may fulfill this requirement by submitting the isolate to the state public health lab. Once the isolate is received by the state public health laboratory it will be submitted to a CDC-contracted laboratory for genotype testing.

Questions?